Skip to main content
Equibles
AAWH logo

AAWH · Ascend Wellness Holdings, Inc. · Metrics

Track AAWH — free

Use AAWH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AAWH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.41 0.00 (-0.44%) At close · Oct 21
Rebalance outlook locked
Market Cap
$84.54M
Shares
203.21M
Volume · Oct 21 32.97K Avg daily vol (3M) 106.49K

AAWH metrics

74 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.41
Market cap
$84.54M

Price action

20 metrics
Price change (1W)
-7.2%
Price change (30D)
-31.3%
Price change (3M)
-4.6%
Price change (6M)
-26.8%
Price change (YTD)
-43.7%
Price change (1Y)
-50.2%
Trailing year
Price change (5Y)
-94.9%
52-week high
$1.08
52-week low
$0.38
Change from 52-week high
-62.2%
Change from 52-week low
+8.0%
Annualized volatility
118.2%
Annualized volatility (3M)
90.7%
Beta
1.3
RSI (14D)
40.1
Price vs SMA 50
-13.7%
Price vs SMA 200
-19.5%
Avg volume (3M)
106,486
Relative volume
0.3
Average dollar volume
$51,842

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
203.21M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 144.9%
EV / EBITDA
5.3×
reciprocal yield 19.0%
EV / EBIT
—
P / sales
0.2×
reciprocal yield 573.5%
P / book
—
FCF yield
-8.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
4.9
reciprocal yield 20.4%
Earnings yield
-133.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
36.7%
Operating margin
-2.2%
Trailing 12 months
Net margin
-23.3%
Gross profit (TTM)
$179.10M
Operating profit (TTM)
−$10.67M
Net income (TTM)
−$113.83M
Trailing 12 months
Diluted EPS (TTM)
$-0.57
FCF margin
-1.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$2.41
Gross profit per diluted share (TTM)
$0.88
Operating profit per diluted share (TTM)
$-0.05
EBITDA per diluted share (TTM)
$0.32
Net income per diluted share (TTM)
$-0.56
Operating cash flow per diluted share (TTM)
$0.09
Free cash flow per diluted share (TTM)
$-0.03
Capital expenditures per diluted share (TTM)
$0.12
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.01
Book value per share
$-0.23

Growth

11 metrics
Revenue growth YoY
-0.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$488.33M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.2%
Revenue CAGR (5Y)
+28.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-12.8%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$64.03M
Free cash flow (TTM)
−$6.95M
Quick ratio
0.9
Interest coverage
-0.2
Net debt / EBITDA
3.9
Return on invested capital
—
Trailing 12 months
Net cash
−$251.82M
Latest balance sheet
Cash & equivalents
$67.00M
Total assets
$888.32M
Total debt
$318.82M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$17.35M
Capital expenditures (TTM)
$24.30M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$2.26M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
27 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1756390 CUSIP 04351N106 Visit website Investor relations